Stroke sequelae
The most common consequence of stroke sequelae is that the patient will have "three paraplegia", speech disorders, swallowing disorders, cognitive disorders, daily activity disorders and urination and defecation disorders.
-
Site of disease:
Cranial muscles -
Infectious :
Not contagious -
Frequent population:
Middle-aged and elderly men -
Related symptoms:
Hemiplegia slow reaction muscle atrophy swallowing disorder incontinence -
Concurrent disease:
Related Drugs
Breviscapus tablets
Manufacturer:
Yunnan Yuyao Biopharmaceutical Co., Ltd.
Breviscapus tablets
Manufacturer:
Hunan Tianjicaotang Pharmaceutical Co., Ltd.
Breviscapus tablets
Manufacturer:
KP Pharmacy Co., Ltd.
Breviscapus tablets
Manufacturer:
Suicheng Pharmaceutical Co., Ltd.
Breviscapus tablets
Manufacturer:
Anhui Shengying Pharmaceutical Co., Ltd.
Pentoxifylline Sodium Chloride Injection
Indication: ① Cerebral blood circulation disorders such as transient cerebral ischemic attack, sequelae of stroke, and brain dysfunction caused by cerebral ischemia; ② Peripheral blood circulation disorders such as thromboembolic vasculitis, abdominal arterial blood circulation disorders, intermittent claudication or rest pain; ③ Inner ear circulation disorders such as sudden deafness, senile tinnitus and deafness; ④ Ocular blood circulation disorders such as diabetic retinal artery embolism.
Pentoxifylline Sodium Chloride Injection
Indication: ① Cerebral blood circulation disorders such as transient cerebral ischemic attack, sequelae of stroke, and brain dysfunction caused by cerebral ischemia; ② Peripheral blood circulation disorders such as thromboembolic vasculitis, abdominal arterial blood circulation disorders, intermittent claudication or rest pain; ③ Inner ear circulation disorders such as sudden deafness, senile tinnitus and deafness; ④ Ocular blood circulation disorders such as diabetic retinal artery embolism.
Pentoxifylline for injection
Indication: 1. Cerebral blood circulation disorders such as transient cerebral ischemic attack, sequelae of stroke, brain dysfunction caused by cerebral ischemia; 2. Peripheral blood circulation disorders such as thromboembolic vasculitis, abdominal arterial blood circulation disorders, intermittent claudication or rest pain; 3. Inner ear circulation disorders such as sudden deafness, senile tinnitus and deafness. 4. Eye blood circulation disorders.
Manufacturer:
Jilin Huinan Changlong BLO-CHEMICAL Pharmaceutcal Co., Ltd.
Pentoxifylline Sodium Chloride Injection
Indication: ① Cerebral blood circulation disorders such as transient cerebral ischemic attack, sequelae of stroke, and brain dysfunction caused by cerebral ischemia; ② Peripheral blood circulation disorders such as thromboembolic vasculitis, abdominal arterial blood circulation disorders, intermittent claudication or rest pain; ③ Inner ear circulation disorders such as sudden deafness, senile tinnitus and deafness; ④ Ocular blood circulation disorders such as diabetic retinal artery embolism.
Manufacturer:
Liaoning Hishen Liansheng Pharmaceutical Co., Ltd.
Pentoxifylline for injection
Indication: 1. Cerebral blood circulation disorders such as transient cerebral ischemic attack, sequelae of stroke, brain dysfunction caused by cerebral ischemia; 2. Peripheral blood circulation disorders such as thromboembolic vasculitis, abdominal arterial blood circulation disorders, intermittent claudication or rest pain; 3. Inner ear circulation disorders such as sudden deafness, senile tinnitus and deafness. 4. Eye blood circulation disorders.
Manufacturer:
Nanjing CHANG AO Pharmaceutical Co., Ltd.
Related Ingredients
-
BREVISCAPIN list
116122-36-2 -
Pentoxifylline list
6493-05-6 -
(+/-)-Verapamil hydrochloride list
152-11-4